Rare disease expert Kym Boycott joins the GENETICS editorial board
We’re pleased to announce that Kym Boycott (Children’s Hospital of Eastern Ontario) has joined the GENETICS Editorial Board. Following Editor-in-Chief Mark Johnston’s call for submissions of human genetics research, Dr. Boycott is a welcome addition to the board’s growing list of editors with expertise in human genetics.
Dr. Boycott is a Medical Geneticist at the Children’s Hospital of Eastern Ontario (CHEO) and Investigator at the CHEO Research Institute. She is an Associate Professor and holds a Tier II Research Chair in Neurogenetics from the Faculty of Medicine at the University of Ottawa. She completed her PhD, MD and FRCPC training in Medical Genetics at the University of Calgary. Dr. Boycott’s research, bridging clinical medicine to basic research, is focused on elucidating the molecular pathogenesis of rare genetic diseases using next-generation sequencing approaches. She has been the recipient of the Canadian Institutes of Health Research Clinical Investigatorship Award from the Institute of Genetics, the SickKids Foundation Young Investigator Award, and the Basil O’Connor March of Dimes Young Investigator Award. She was the Lead Investigator of the Genome Canada and CIHR funded ‘Finding of Rare Disease Genes in Canada’ (FORGE Canada) project, which investigated the molecular etiology of more than 250 rare pediatric diseases, identifying the cause in more than 55% and making 67 novel disease gene discoveries. She currently leads the Genome Canada and CIHR funded large-scale project ‘Enhanced CARE for RARE Genetic Diseases in Canada,’ which is focused on improving the clinical care of patients and families by expanding and improving the diagnosis and treatment of rare diseases.